Pharma Journalist -

Nexcelom Bioscience announced that it has received a strategic investment from Ampersand Capital Partners. The funding will be primarily used to support Nexcelom's worldwide growth…
Read More...

Global pharmaceutical company Mylan N.V. announced the U.S. launch of the oncology drug Mitomycin for Injection USP, 5 mg/vial, 20 mg/vial and 40 mg/vial Single Dose Vials, a generic…
Read More...

Akcea Therapeutics United Kingdom (UK) Ltd announced that volanesorsen has been granted a positive scientific opinion through the Early Access to Medicines Scheme (EAMS) by the UK’s…
Read More...

Kalytera Therapeutics announced that it has begun development of a novel cannabinoid-based compound for the treatment of acute and chronic pain. Patents for this compound have been…
Read More...

Standardizing and personalizing insulin therapy management for hospitalized patients is a goal Piedmont Healthcare is poised to achieve through expanded use of Glytec’s eGlycemic…
Read More...

Elligo Health Research, which improves clinical trial access by engaging the 97 percent of physicians currently not offering clinical research to their patients, announced today $16…
Read More...

Bicycle Therapeutics, a biotechnology company pioneering a new class of therapeutics based on its proprietary bicyclic peptide (Bicycle) product platform, announced the promotion of…
Read More...

Intezyne, a clinical-stage biopharmaceutical company developing novel anti-cancer therapies, announced that it has partnered with Exosome Diagnostics, a privately held company focused…
Read More...

SMi Group reports: With updates on the recent developments in the industry, and the ever-increased net worth of the medical devices market within the US especially, SMi's Pre-Filled…
Read More...

SMi Group reports: The chronic pain epidemic today affects thousands of patients worldwide. It is now a point of concern for the pharmaceutical industry, for the healthcare industry and…
Read More...